Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)
dc.conference.date | MAR 02-04, 2020 | |
dc.conference.title | European-Society-for-Medical-Oncology (ESMO) Targeted Anticancer Therapies Congress (TAT) | |
dc.contributor.author | Le Tourneau, C. | |
dc.contributor.author | Rischin, D. | |
dc.contributor.author | Groenland, S. | |
dc.contributor.author | Lim, A. | |
dc.contributor.author | Martin-Liberal, J. | |
dc.contributor.author | Moreno, V. | |
dc.contributor.author | Trigo, J. M. | |
dc.contributor.author | Mathew, M. | |
dc.contributor.author | Cho, D. | |
dc.contributor.author | Hansen, A. | |
dc.contributor.author | Baz, D. Vincente | |
dc.contributor.author | Maio, M. | |
dc.contributor.author | Italiano, A. | |
dc.contributor.author | Bauman, J. | |
dc.contributor.author | Chisamore, M. | |
dc.contributor.author | Zhou, H. | |
dc.contributor.author | Ellis, C. | |
dc.contributor.author | Ballas, M. | |
dc.contributor.author | Hoos, A. | |
dc.contributor.author | Angevin, E. | |
dc.contributor.authoraffiliation | [Le Tourneau, C.] Inst Curie, Paris, France | |
dc.contributor.authoraffiliation | [Rischin, D.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia | |
dc.contributor.authoraffiliation | [Rischin, D.] Univ Melbourne, Melbourne, Vic, Australia | |
dc.contributor.authoraffiliation | [Groenland, S.] Netherlands Canc Inst, Antoni van Leeuwenhoek, Amsterdam, Netherlands | |
dc.contributor.authoraffiliation | [Lim, A.] Linear Clin Res & Sir Charles Gairdner Hosp, Nedlands, WA, Australia | |
dc.contributor.authoraffiliation | [Martin-Liberal, J.] Vall dHebron Inst Oncol VHIO Cellex Cente, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Moreno, V.] Univ Hosp Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain | |
dc.contributor.authoraffiliation | [Trigo, J. M.] Hosp Univ Virgen Victoria, Malaga, Spain | |
dc.contributor.authoraffiliation | [Mathew, M.] Columbia Univ, Med Ctr, New York, NY USA | |
dc.contributor.authoraffiliation | [Cho, D.] NYU, Langone Med Ctr, New York, NY USA | |
dc.contributor.authoraffiliation | [Hansen, A.] Princess Margaret Canc Ctr, Toronto, ON, Canada | |
dc.contributor.authoraffiliation | [Baz, D. Vincente] Hosp Univ Virgen Macarena, Seville, Spain | |
dc.contributor.authoraffiliation | [Maio, M.] Univ Hosp Siena, Siena, Italy | |
dc.contributor.authoraffiliation | [Italiano, A.] Inst Bergonie, Bordeaux, France | |
dc.contributor.authoraffiliation | [Bauman, J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA | |
dc.contributor.authoraffiliation | [Chisamore, M.] Merck & Co Inc, N Wales, PA USA | |
dc.contributor.authoraffiliation | [Zhou, H.] GSK, Collegeville, PA USA | |
dc.contributor.authoraffiliation | [Ellis, C.] GSK, Collegeville, PA USA | |
dc.contributor.authoraffiliation | [Ballas, M.] GSK, Collegeville, PA USA | |
dc.contributor.authoraffiliation | [Hoos, A.] GSK, Collegeville, PA USA | |
dc.contributor.authoraffiliation | [Angevin, E.] Gustave Roussy Inst Cancerol, Villejuif, France | |
dc.contributor.funder | GlaxoSmithKline (GSK) | |
dc.contributor.funder | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA | |
dc.date.accessioned | 2025-01-07T15:23:55Z | |
dc.date.available | 2025-01-07T15:23:55Z | |
dc.date.issued | 2020-03-01 | |
dc.identifier.doi | 10.1016/j.annonc.2020.01.049 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753420359822/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27107 | |
dc.identifier.wosID | 521074400002 | |
dc.issue.number | 1 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de la Victoria | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.organization | SAS - Hospital Universitario Virgen Macarena | |
dc.page.number | S1-S1 | |
dc.publisher | Oxford univ press | |
dc.rights.accessRights | open access | |
dc.title | Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC) | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 31 | |
dc.wostype | Meeting Abstract |